An international group of researchers led by Pompeu Fabra University has discovered the nanomachine that controls ...
Every time our body encounters a new disease-causing agent, a crucial defense system called adaptive immunity comes into play ...
Maze Therapeutics uses its Compass genetics platform to advance kidney and obesity drugs, with MZE829 Phase 2 data due in ...
The head of the Department of Health and Human Services has spent decades promoting vaccine skepticism and has now revamped the US childhood immunization schedule to have one-third fewer recommended ...
“If customers are still having an issue, we encourage them to restart their devices to reconnect to the network,” Verizon ...
A research team led by Professor Chen Peng from the College of Chemistry and Molecular Engineering at Peking University has ...
Preliminary BRIUMVI U.S. fourth quarter and full year 2025 net product revenue of approximately $182 million and $594 million, respectively Full Year 2026 target total global revenue of approximately ...
A research team at the Medical University of Vienna has discovered a new approach to treating a particularly frequent and ...
SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
A research team at the Medical University of Vienna has discovered a new approach to treating a particularly frequent and difficult-to-treat form of lung cancer. The study shows that a combination of ...
Discover related content in your Obsidian vault through tag-based connections. This plugin displays notes that share tags with your currently active note, helping you find related notes and build ...
Zoldonrasib targets KRAS G12D-mutated non-small cell lung cancer, receiving FDA breakthrough therapy designation for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback